LivaNova ( (LIVN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LivaNova’s stock has gained positive momentum following the announcement of a substantial increase in Medicare reimbursement rates for their VNS Therapy, set to take effect in 2026. This news has prompted analysts to raise their price targets for the company, highlighting strategic growth plans and the potential commercialization of their OSA device as significant factors. Additionally, LivaNova’s introduction of 2030 financial targets and expectations for the OSA business to break even by 2029 have further bolstered investor confidence.
More about LivaNova
YTD Price Performance: 18.52%
Average Trading Volume: 556,295
Technical Sentiment Signal: Buy
Current Market Cap: $3.02B
For further insights into LIVN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.